MaaT Pharma SA (EPA:MAAT)

MaaT Pharma Statistics

Total Valuation

MaaT Pharma has a market cap or net worth of EUR 104.43 million. The enterprise value is 103.80 million.

Market Cap	104.43M
Enterprise Value	103.80M

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

MaaT Pharma has 18.82 million shares outstanding.

Current Share Class	18.82M
Shares Outstanding	18.82M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.42%
Owned by Institutions (%)	13.34%
Float	9.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.08
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.34
EV / Sales	22.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.16

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.62%
Revenue Per Employee	69,600
Profits Per Employee	-477,862
Employee Count	65
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.71% in the last 52 weeks. The beta is 0.43, so MaaT Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-9.71%
50-Day Moving Average	6.77
200-Day Moving Average	5.20
Relative Strength Index (RSI)	38.81
Average Volume (20 Days)	76,610

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MaaT Pharma had revenue of EUR 4.52 million and -31.06 million in losses.

Revenue	4.52M
Gross Profit	4.52M
Operating Income	-28.33M
Pretax Income	-31.06M
Net Income	-31.06M
EBITDA	-28.10M
EBIT	-28.33M
Earnings Per Share (EPS)	n/a

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	227,000
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-626.19%
Pretax Margin	-686.58%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MaaT Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-29.74%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1